Senti Biosciences (SNTI) Appoints Fran Schulz to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Senti Biosciences (SNTI) Appoints Fran Schulz to its Board

Senti Bio Appoints Fran Schulz to Board of Directors

December 2, 2024 7:00 AM EST

SOUTH SAN FRANCISCO, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (Senti Bio or the Company), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that it has appointed Fran Schulz, a highly experienced biotechnology and financial executive, to the Senti Bio Board of Directors (Board).

We are excited to welcome Fran to the Senti Bio Board of Directors, said Timothy Lu, MD, PhD, Chief Executive Officer and Co-Founder of Senti Bio. Fran's deep expertise in the life sciences industryspanning finance, strategic planning,... More